ADULT T-CELL LEUKEMIA/LYMPHOMA
Clinical trials for ADULT T-CELL LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT T-CELL LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted attack on rare blood cancers shows promise
Disease control OngoingThis study is testing a new treatment approach for aggressive types of T-cell lymphoma, a rare blood cancer. It combines a targeted drug that seeks out cancer cells with standard chemotherapy drugs. The goal is to see if this combination is safe and more effective at controlling …
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early trial tests new combo for Tough-to-Treat blood cancer
Disease control TerminatedThis early-stage study aims to find the safest and most effective dose of the drug lenalidomide when given alongside a standard chemotherapy regimen (called EPOCH) for adult T-cell leukemia/lymphoma (ATLL), a rare and aggressive cancer. It will involve about 30 adults with ATLL t…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug trial offers hope for Tough-to-Treat blood cancer
Disease control OngoingThis study is testing an oral drug called valemetostat in adults whose peripheral T-cell lymphoma has come back or hasn't responded to prior treatments. The main goal is to see if the drug safely shrinks tumors and for how long. It includes 155 participants and focuses on measuri…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC